Memphasys Ltd Targets Global Expansion in Fertility and Diagnostics
Memphasys Completes Felix System Clinical Trial, Shares Rise Past 14%
Memphasys Says Publication of Study Demonstrates Oxidative Stress Profiling System Potential
Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China
Memphasys Ltd to Quote New Shares on ASX
Memphasys Ltd Announces Director Resignation
Memphasys Ltd Issues New Unquoted Loan Options
Memphasys Ltd Unveils Product Development Timelines
Memphasys Ltd Eyes European Market With New Strategies
Memphasys Ltd Nears Completion of Felix System Trial
ASX Small-Cap Stocks to Watch
Memphasys Ltd Issues Supplementary Prospectus
Memphasys Ltd Shareholders to Vote on Share Issuance
Memphasys Ltd: Annual Financial Report for the year ended 30 June 2024
Memphasys Launches AU$2 Million Capital Raise for Japanese Clinical Trial
Memphasys Ltd Announces Voluntary Trading Suspension
Memphasys Ltd Addresses Cleansing Notice Issue
Memphasys Ltd Advances Equine Fertility Technology
Memphasys Ltd Options Cease Amid Unmet Conditions
Memphasys Ltd Sets Stringent Insider Trading Policy